Image for illustrative purposes only. Not a real photo.

Zai Lab gains European orphan drug designation

Written by Isaac FrancisPublished Jun 16, 2026, 11:26 AM

Zai Lab (NASDAQ:ZLAB) has received European orphan drug designation for its antibody-drug conjugate targeting 375,000 annual lung cancer cases.

More ways to discover